All links outside IUPHAR will open in a new window.
"Nature Reviews Drug Discovery"
IUPHAR has formed a recent, informal collaboration with "Nature Reviews Drug Discovery". The first article by IUPHAR was published soon after the launch of the journal.
Fredholm, B. B., Fleming, W. W., Vanhoutte, P. M. and Godfraind, T. (2002). The role of pharmacology in drug discovery. Nature Rev.Drug Discov., 1, 237-248.
"Pharmacological Reviews"
IUPHAR has a longstanding, formal collaboration with "Pharmacological Reviews". The official reports from the IUPHAR Committee on Receptor Nomenclature
and Drug Classification are published in the journal. The 1994 publications appeared as a special issue to coincide with the
XIIIth International Congress of Pharmacology in Munich, Germany. The 2002 publications appeared as a special issue to celebrate 10 years
of the publishing collaboration between IUPHAR and ASPET. A complimentary copy was given to each delegate at the XIVth World Congress of Pharmacology in San Francisco, USA. Single copies of these issues and reprint packages can be purchased by
contacting ASPET.
Kenakin, T. P., Bond, R. A. and Bonner, T. I. (1992). International Union
of Pharmacology. II. Definition of pharmacological receptors. Pharmacol. Rev., 44, 351-362.
Spedding, M. and Paoletti, R. (1992). International Union of Pharmacology.
III. Classification of calcium channels and the sites of action of drugs
modifying channel function. Pharmacol. Rev., 44, 363-376.
Vanhoutte, P. M., Barnard, E. A., Cosmides, G. J., Humphrey, P. P. A., Spedding, M. and Godfraind, T. (1994). International Union of Pharmacology. I. Committee on Receptor Nomenclature and Drug Cassification. Pharmacol. Rev., 46, 111-116.
Bylund, D. B., Eikenberg, D. C., Hieble, J. P., Langer, S. Z., Lefkowitz,
R. J., Minneman, K. P., Molinoff, P. B., Ruffolo, R. R. Jr. and Trendelenburg,
U. (1994). IV. International Union of Pharmacology nomenclature of adrenoceptors.
Pharmacol. Rev., 46, 121-136.
Masaki T., Vane, J. R. and Vanhoutte, P. M. (1994). V. International
Union of Pharmacology Nomenclature of endothelin receptors. Pharmacol.
Rev., 46, 137-142.
Fredholm B. B., Abbracchio, M. P., Burnstock, G., Daly, J. W., Harden,
T. K., Jacobson, K. A., Leff, P. and Williams, M. (1994). VI. Nomenclature
and classification of purinoceptors. Pharmacol. Rev., 46, 143-156.
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R.,
Mylecharane, E. J., Saxena, P. R. and Humphrey, P. P. A. (1994) VII. International
Union of Pharmacology classification of receptors for 5-hydroxytrytamine
(Serotonin). Pharmacol. Rev., 46, 157-203.
Coleman, R. A., Smith, W. L. and Narumiya, S. (1994). VIII. International
Union of Pharmacology classification of prostanoid receptors: Properties,
distribution and structure of the receptors and their subtypes. Pharmacol.
Rev., 46, 205-229.
Jenkinson, D. H., Barnard, E. A., Hoyer, D., Humphrey, P. P. A., Leff,
P. and Shankley, N. P. (1995). International Union of Pharmacology Committee
on Receptor Nomenclature and Drug Classification. IX. Recommendations
on terms and symbols in quantitative pharmacology. Pharmacol. rev.47, 255-265.
Hieble, J. P., Bylund, D. B., Clarke, D. E., Eikenburg D. C., Langer,
S. Z., Lefkowitz, R. J., Minneman, K. P. and Ruffolo, R. R. Jr. (1995).
X. International Union of Pharmacology. Recommendation for nomenclature
of α1-adrenoceptors:
consensus update.
Pharmacol. Rev., 47, 267-270.
Vanhoutte, P. M., Humphrey, P. P. A. and Spedding, M. (1996). International
Union of Pharmacology. XI. Recommendations for nomenclature of new receptor
subtypes. Pharmacol. Rev., 48, 1-2.
Dhawan, B. N., Cesselin, F., Raghubir, R., Reisine, T., Bradley, P. B.,
Portoghese, P. S. and Hamon, M. (1996). International Union of Pharmacology.
XII. Classification of opioid receptors. Pharmacol. Rev., strong>48,567-592.
Hill, S. J., Ganellin, C. R., Timmerman, H., Schwartz, J-C., Shankley, N. P., Young, J. M., Schunack, W., Levi, R. and Haas, H. L. (1997). International Union of Pharmacology. XIII. Classification of histamine receptors.
Pharmacol.
rev.49, 253-278.
Moncada, S., Higgs, A. and Furchgott, R. (1997). International Union of Pharmacology. XIV. Nomenclature in nitric oxide research.
Pharmacol.
Rev., 49, 137-142.
Barnard, E., A., Skolnick, P., Olsen, R. W., Mohler, H., Sieghart, W., Biggio, G., Braestrup, C., Bateson, A. N. and Langer, S. Z. (1998). International Union of Pharmacology. XV. Subtypes of γ-aminobutyric acidA receptors. Classification on the basis of subunit structure and receptor function.
Pharmacol. Rev.,50,
291-313.
Michel, M. C., Beck-Sickinger, A., Cox, H., Doods, H. N., Herzog, H., Larhammar, D., Quirion, R., Schwartz, T., Wahlestedt, C. and Westfall, T. (1998). International Union of Pharmacology. XVI. Recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors.
Pharmacol. Rev., 50, 143-150.
Caulfield, M. P. and Birdsall, N. J. M. (1998) International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.
Pharmacol. Rev., 50, 279-290.
Harmar, A. J., Arimura, A., Gozes, I., Journot, L., Laburthe, M., Pisegna, J. R., Rawlings, S. R., Robberecht, P., Said, S. I., Sreedharan, S. P., Wank, S. A. and Waschek, J. A. (1998). International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
Pharmacol. Rev., 50, 265-269.
Humphrey, P. P. A. and Barnard, E. A. (1998). International Union of Pharmacology. XIX. The IUPHAR Receptor Code: A proposal for an alphanumeric classification system.
Pharmacol. Rev., 50, 271-277.
Lukas R. J., Changeux J. P., Le Novere, N., Albuquerque, E. X., Balfour, D. J. K., Berg, D. K., Bertrand, D., Chiappinelli, V. A., Clarke, P. B. S., Collins, A. C., Dani, J. A., Grady, S. R., Kellar, K. J., Lindstrom, J. M., Marks, M. J., Quik, M., Taylor, P. W. and Wonnacott, S. (1999). International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits.
Pharmacol. Rev., 51, 397-401.
Noble, F., Wank, S. A., Crawley, J. N., Bradwejn, J., Seroogy, K. B., Hamon, M. and Roques, B. P. (1999). International Union of Pharmacology. XXI. Structure, distribution and functions of cholecystokinin receptors. Pharmacol. Rev., 51, 745-781.
Murphy, P. M., Baggiolini, M., Charo, I. F., Hebert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J. and Power, C. A. (2000). International Union of Pharmacology. XXII. Nomenclature for chemokine receptors.
Pharmacol. Rev., 52, 145-176.
de Gasparo, M., Catt, K.J., Inagami, T., Wright., J.W. and Unger, T. (2000). International Union of Pharmacology. XXIII. The angiotensin II receptors.
Pharmacol. Rev., 52, 415-472.
Khakh, B. S., Burnstock, G., Kennedy, C., King, B. F., North R. A., éguéla, P., Voigt, M. and Humphrey, P. P. A. (2001). International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits.
Pharmacol. Rev., 53, 107-118.
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K-A. and Linden, J. (2001). International Union of Pharmacology. XXV. Nomencalture and classification of adenosine receptors.
Pharmacol. Rev., 53,
527-552.
Abernathy, D.R. and Ruffolo, R.R. Jr. (2002). International Union of Pharmacology. XXVI. Nomenclature and Pharmacological Reviews. Pharmacol. Rev., 54, 159.
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., Mechoulam, R. and Pertwee, R. G. (2002). International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.
Pharmacol. Rev., 54,
161-202.
Hollenberg, M. D. and Compton, S. J. (2002). International Union of Pharmacology. XXVIII. Proteinase-activated receptors.
Pharmacol. Rev., 54,
203-218.
Davenport, A. P. (2002). International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature.
Pharmacol. Rev., 54,
219-226.
Murphy, P. M. (2002). International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature.
Pharmacol. Rev., 54, 227-230.
Spedding, M., Bonner, T. I. and Watson, S. P. (2002). International Union of Pharmacology. XXXI. Recommendations for the nomenclature of multimeric, G protein-coupled receptors.
Pharmacol. Rev., 54, 231-232.
Poyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A. and Foord, S. M. (2002). International Union of Pharmacology. XXXII. The mammalian CGRP, adrenomedullin, amylin and calcitonin receptors.
Pharmacol. Rev., 54: 233-246.
Bowery, N. G., Bettler, B., Froestl, W., Gallagher, J. P., Marshall, F., Raiteri, M., Bonner, T. I. and Enna, S. J. (2002). International Union of Pharmacology. XXXIII. Mammalian GABAB receptors: Structure and function.
Pharmacol. Rev., 54: 247-264.
Chun, J., Goetzl, E. J., Hla, T. L., Igarashi, Y., Lynch, K. R., Moolenaar, W. H., Pyne, S. and Tigyi, G. (2002). International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature.
Pharmacol. Rev., 54: 265-270.
Richard L. Hauger, Dimitri E. Grigoriadis, Mary F. Dallman, Paul M. Plotsky, Wylie W. Vale, and Frank M. Dautzenberg. International Union of Pharmacology. XXXVI. Current Status of the Nomenclature for Receptors for Corticotropin-Releasing Factor and Their Ligands
Pharmacol Rev. 2003 55: 21-26.
Kelly E. Mayo, Laurence J. Miller, Dominique Bataille, Stéphane Dalle, Burkhard Göke, Bernard Thorens, and Daniel J. Drucker. International Union of Pharmacology. XXXV. The Glucagon Receptor Family. Pharmacol Rev. 2003 55: 167-194.
Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, Simonetta Nicosia, Charles N. Serhan, Takao Shimizu, and Takehiko Yokomizo. International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors. Pharmacol Rev. 2003 55: 195-227.
William A. Catterall, K. G. Chandy, D. E. Clapham, G. A. Gutman, F. Hofmann, A. J. Harmar, D. R. Abernethy, and M. Spedding
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Pharmacol Rev 2003 55: 573-574.
William A. Catterall, Alan L. Goldin, and Stephen G. Waxman
International Union of Pharmacology. XXXIX. Compendium of Voltage-Gated Ion Channels: Sodium Channels
Pharmacol Rev 2003 55: 575-578.
William A. Catterall, Joerg Striessnig, Terrance P. Snutch, and Edward Perez-Reyes
International Union of Pharmacology. XL. Compendium of Voltage-Gated Ion Channels: Calcium Channels
Pharmacol Rev 2003 55: 579-581.
George A. Gutman, K. George Chandy, John P. Adelman, Jayashree Aiyar, Douglas A. Bayliss, David E. Clapham, Manuel Covarriubias, Gary V. Desir, Kiyoshi Furuichi, Barry Ganetzky, Maria L. Garcia, Stephan Grissmer, Lily Y. Jan, Andreas Karschin, Donghee Kim, Sabina Kuperschmidt, Yoshihisa Kurachi, Michel Lazdunski, Florian Lesage, Henry A. Lester, David McKinnon, Colin G. Nichols, Ita O'Kelly, Jonathan Robbins, Gail A. Robertson, Bernardo Rudy, Michael Sanguinetti, Susumu Seino, Walter Stuehmer, Michael M. Tamkun, Carol A. Vandenberg, Aguan Wei, Heike Wulff, and Randy S. Wymore
International Union of Pharmacology. XLI. Compendium of Voltage-Gated Ion Channels: Potassium Channels
Pharmacol Rev 2003 55: 583-586.
Franz Hofmann, Martin Biel, and U. Benjamin Kaupp
International Union of Pharmacology. XLII. Compendium of Voltage-Gated Ion Channels: Cyclic Nucleotide-Modulated Channels
Pharmacol Rev 2003 55: 587-589.
David E. Clapham, Craig Montell, Guenter Schultz, and David Julius
International Union of Pharmacology. XLIII. Compendium of Voltage-Gated Ion Channels: Transient Receptor Potential Channels
Pharmacol Rev 2003 55: 591-596.
Richard R. Neubig, Michael Spedding, Terry Kenakin, and Arthur Christopoulos
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology
Pharmacol Rev 2003 55: 597-606.
Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu, and Takehiko Yokomizo
International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
Pharmacol Rev 2004 56: 149-157.
L. M. Fredrik Leeb-Lundberg, Francois Marceau, Werner Müller-Esterl, Douglas J. Pettibone, and Bruce L. Zuraw International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences
Pharmacol Rev. 2005 57: 27-77.
Steven M. Foord, Tom I. Bonner, Richard R. Neubig, Edward M. Rosser, Jean-Phillipe Pin, Anthony P. Davenport, Michael Spedding, And Anthony J. Harmar International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List. Pharmacol Rev. 2005 Jun; 57(2):279-88.
Frank H. Yu, Vladimir Yarov-Yarovoy, George A. Gutman, and William A. Catterall. Overview of Molecular Relationships in the Voltage-Gated Ion Channel Superfamily. Pharmacol Rev 2005 57: 387-395.
William A. Catterall, Alan L. Goldin, and Stephen G. Waxman. International Union of Pharmacology. XLVII. Nomenclature and Structure-Function Relationships of Voltage-Gated Sodium Channels. Pharmacol Rev 2005 57: 397-409.
William A. Catterall, Edward Perez-Reyes, Terrance P. Snutch, and Joerg Striessnig. International Union of Pharmacology. XLVIII. Nomenclature and Structure-Function Relationships of Voltage-Gated Calcium Channels. Pharmacol Rev 2005 57: 411-425.
David E. Clapham, David Julius, Craig Montell, and Günter Schultz. International Union of Pharmacology. XLIX. Nomenclature and Structure-Function Relationships of Transient Receptor Potential Channels. Pharmacol Rev 2005 57: 427-450.
David E. Clapham and David L. Garbers. International Union of Pharmacology. L. Nomenclature and Structure-Function Relationships of CatSper and Two-Pore Channels. Pharmacol Rev 2005 57: 451-454.
Franz Hofmann, Martin Biel, and U. Benjamin Kaupp. International Union of Pharmacology. LI. Nomenclature and Structure-Function Relationships of Cyclic Nucleotide-Regulated Channels. Pharmacol Rev 2005 57: 455-462.
Aguan D. Wei, George A. Gutman, Richard Aldrich, K. George Chandy, Stephan Grissmer, and Heike Wulff. International Union of Pharmacology. LII. Nomenclature and Molecular Relationships of Calcium-Activated Potassium Channels. Pharmacol Rev 2005 57: 463-472.
George A. Gutman, K. George Chandy, Stephan Grissmer, Michel Lazdunski, David Mckinnon, Luis A. Pardo, Gail A. Robertson, Bernardo Rudy, Michael C. Sanguinetti, Walter Stühmer, and Xiaoliang Wang. International Union of Pharmacology. LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium Channels. Pharmacol Rev 2005 57: 473-508.
Yoshihiro Kubo, John P. Adelman, David E. Clapham, Lily Y. Jan, Andreas Karschin, Yoshihisa Kurachi, Michel Lazdunski, Colin G. Nichols, Susumu Seino, and Carol A. Vandenberg. International Union of Pharmacology. LIV. Nomenclature and Molecular Relationships of Inwardly Rectifying Potassium Channels. Pharmacol Rev 2005 57: 509-526.
Steve A. N. Goldstein, Douglas A. Bayliss, Donghee Kim, Florian Lesage, Leigh Daniel Plant, and Sindhu Rajan. International Union of Pharmacology. LV. Nomenclature and Molecular Relationships of Two-P Potassium Channels. Pharmacol Rev 2005 57: 527-540.
Anthony P. Davenport, Tom I. Bonner, Steven M. Foord, Anthony J. Harmar, Richard R. Neubig, Jean-Philippe Pin, Michael Spedding, Masayasu Kojima, and Keniji Kangawa. International Union of Pharmacology. LVI. Ghrelin Receptor Nomenclature, Distribution, and Function. Pharmacol Rev 2005 57: 541-546.
Ross A. Bathgate, Richard Ivell, Barbara M. Sanborn, O. David Sherwood, and Roger J. Summers. International Union of Pharmacology LVII: Recommendations for the Nomenclature of Receptors for Relaxin Family Peptides. Pharmacol Rev 2006 58: 7-31.
